Annette Insurance (AWH, Financial) experienced a significant stock movement, with a drop of 5.17% in its share price. The stock is currently valued at $0.770 per share, with a trading volume of 128,218 shares, a turnover rate of 0.80%, and a price volatility of 7.39%.
Recent financial reports reveal that AWH recorded a revenue of $2.42 million and a net loss of $3.53 million, resulting in an earnings per share of -$0.28. The company's gross profit was $1.42 million, and it has a price-to-earnings ratio of -0.58. No institutional recommendations for buying, holding, or selling the stock are currently available.
Within the life sciences industry, where Annette Insurance operates, the sector has seen an overall increase of 0.22%. Noteworthy stocks showing significant upticks in this sector include Mainz Biomed N.V., Bioaffinity Technologies, Inc., and T2 Biosystems, Inc. Active stocks with high turnover rates include Mainz Biomed N.V. at 14.05%, Applied DNA Sciences, Inc. at 13.91%, and Endra Life Sciences Inc. at 7.06%. Stocks displaying notable volatility include Mainz Biomed N.V., Bioaffinity Technologies Inc with warrants expiring on 07/09/2027, and Bioaffinity Technologies, Inc., with volatility rates of 27.62%, 15.87%, and 15.42% respectively.
Annette Insurance, under the business name Aspira Women's Health Inc, specializes in the development and commercialization of diagnostic tests for gynecological diseases. Its product portfolio includes OvaSuite, a series of blood tests that use proprietary algorithms combined with patient characteristics, OvaWatch for assessing ovarian cancer risk in women with adnexal masses, and Ova1Plus, which combines two FDA-approved tests for women with pelvic masses planning surgery.
